Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find attached the details of the proposed schedule of Analyst/Institutional Investor meeting(s). Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find attached the details of the proposed schedule of Analyst/Institutional Investor meeting(s). Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
We wish to inform you that, the Board of Directors have on February 22, 2023 approved allotment of 14,000 Equity Shares under the ESOP 2010 Plan of the Company. Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find attached the details of the proposed schedule of Analyst/Institutional Investor meeting(s). Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find attached the details of the proposed schedule of Analyst/Institutional Investor meeting(s). Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find attached the details of the proposed schedule of Analyst/Institutional Investor meeting(s). Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('Listing Regulations'), and SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 ('September 9 Circular'), we hereby inform you that Mr. Rajat Kalra has tendered his resignation from the position of Company Secretary and Compliance Officer of the Company (i.e. Dr. Lal PathLabs Limited) on February 14, 2023, due to some personal reasons. His last working day will be on or before May 04, 2023 and shall be informed to your office in due course. The Board will announce the successor in due course and the same shall be intimated to the Stock Exchange(s). The details required under Regulation 30 of the Listing Regulations read September 9 Circular are enclosed as 'Annexure A'. You are requested to kindly take the aforesaid information on record and oblige. Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith newspaper advertisement(s) published today i.e. February 09, 2023 in Financial Express (English Edition) and Jansatta (Hindi Edition), with respect to completion of dispatch of Postal Ballot Notice dated February 02, 2023, electronically, to the Shareholders of the Company. Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Financial Results Conference Call Transcript of the Company for Q3 FY23. Dr. Lal PathLabs Ltd - 539524 - Postal Ballot Notice
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Postal Ballot Notice dated February 02, 2023 ('Notice') together with the Explanatory Statement(s) thereto seeking approval of the Shareholders for the Resolution(s) mentioned therein, through Postal Ballot by remote e-voting only ('remote e-voting').